Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4USF

Human SLK with SB-440719

Summary for 4USF
Entry DOI10.2210/pdb4usf/pdb
Related4USD 4USE
DescriptorSTE20-LIKE SERINE/THREONINE-PROTEIN KINASE, 4-[4-(6-methoxynaphthalen-2-yl)-1H-imidazol-5-yl]pyridine (3 entities in total)
Functional Keywordstransferase
Biological sourceHOMO SAPIENS (HUMAN)
Cellular locationCytoplasm : Q9H2G2
Total number of polymer chains2
Total formula weight69983.50
Authors
Elkins, J.M.,Salah, E.,Szklarz, M.,von Delft, F.,Bountra, C.,Edwards, A.M.,Knapp, S. (deposition date: 2014-07-07, release date: 2015-07-22, Last modification date: 2024-05-08)
Primary citationElkins, J.M.,Fedele, V.,Szklarz, M.,Abdul Azeez, K.R.,Salah, E.,Mikolajczyk, J.,Romanov, S.,Sepetov, N.,Huang, X.P.,Roth, B.L.,Al Haj Zen, A.,Fourches, D.,Muratov, E.,Tropsha, A.,Morris, J.,Teicher, B.A.,Kunkel, M.,Polley, E.,Lackey, K.E.,Atkinson, F.L.,Overington, J.P.,Bamborough, P.,Moller, S.,Price, D.J.,Willson, T.M.,Drewry, D.H.,Knapp, S.,Zuercher, W.J.
Comprehensive Characterization of the Published Kinase Inhibitor Set.
Nat.Biotechnol., 34:95-, 2016
Cited by
PubMed Abstract: Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small-molecule ATP-competitive kinase inhibitors that was recently made freely available with the aim of expanding research in this field and as an experiment in open-source target validation. We screen the set in activity assays with 224 recombinant kinases and 24 G protein-coupled receptors and in cellular assays of cancer cell proliferation and angiogenesis. We identify chemical starting points for designing new chemical probes of orphan kinases and illustrate the utility of these leads by developing a selective inhibitor for the previously untargeted kinases LOK and SLK. Our cellular screens reveal compounds that modulate cancer cell growth and angiogenesis in vitro. These reagents and associated data illustrate an efficient way forward to increasing understanding of the historically untargeted kinome.
PubMed: 26501955
DOI: 10.1038/NBT.3374
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon